⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2777562 | 1.00 | — | — | |
| SCHEMBL1570079 | 1.00 | — | — | |
| SCHEMBL15074981 | 1.00 | — | — | |
| SCHEMBL16566045 | 1.00 | — | — | |
| SCHEMBL13487235 | 0.82 | — | — | |
| Naphthalene SCHEMBL29056156 | 0.82 | UGT2B7 (0.39) | — | |
| SCHEMBL476387 | 0.80 | PAX8 (0.44) | — | |
| SCHEMBL15198905 | 0.80 | — | — | |
| SCHEMBL17866736 | 0.80 | PAX8 (0.40) | — | |
| SCHEMBL489573 | 0.80 | PAX8 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117746339-A | Household safety monitoring system and method based on thermal imaging and identity recognition technology | 健而康科技信息服务(中山)有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-117155535-A | Optical safety communication system and optical safety communication method | 天府兴隆湖实验室 | 2023-12-01 | — | — | CN | claimed |
| CN-117081723-A | Optical safety communication system and optical safety communication method | 天府兴隆湖实验室 | 2023-11-17 | — | — | CN | claimed |
| EP-4022046-A2 | RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED HA FOR REPLICATION IN EGGS | Wisconsin Alumni Research Foundation (WARF) (US) | 2022-07-06 | — | — | EP | claimed |
| US-6359061-B1 | COMBINATORIAL LIBRARIES ARE USEFUL FOR SCREENING IN BIOLOGCAL ASSAYS IN ORDER TO IDENTIFY PHARMACEUTICALLY USEFUL COMPOUNDS | ISIS PHARMACEUTICALS, INC. | 2002-03-19 | — | — | US | claimed |
| US-12507902-B2 | System and method for monitoring of atrial fibrillation, blood glucose and psychophisical condition based on heart rate variability | INNOVATION DOOEL (MK) | 2025-12-30 | — | — | US | disclosed |
| EP-4505330-B1 | METHOD FOR EXECUTING AN AUTHENTICATION OF A USER FOR A TRANSACTION | THALES DIS FRANCE SAS (FR) | 2025-12-17 | — | — | EP | disclosed |
| US-20250361280-A1 | CONJUGATED HEPCIDIN MIMETICS | PROTAGONIST THERAPEUTICS INC (US) | 2025-11-27 | — | — | US | disclosed |
| US-20250263469-A1 | POLYPEPTIDES TARGETING SARS-COV-2 AND RELATED COMPOSITIONS AND METHODS | THE HOSPITAL FOR SICK CHILDREN (CA) | 2025-08-21 | — | — | US | disclosed |
| US-20250240614-A1 | SUBSCRIBER IDENTITY MODULE SWITCHING BASED ON PREDICTED UTILITY | QUALCOMM INCORPORATED | 2025-07-24 | — | — | US | disclosed |
| CN-119855607-A | Carbon chain substance for regulating transmembrane transport and fluidity of cell membrane, preparation and application | 太阳雨林(北京)生物医药有限公司 | 2025-04-18 | — | — | CN | disclosed |
| EP-4520348-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | Sunforest (Beijing) Biopharma Ltd (CN) | 2025-03-12 | — | — | EP | disclosed |
| US-8350042-B2 | Antiviral compounds for the treatment of HCV infection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-01-08 | — | — | US | disclosed |
| US-20120053115-A1 | Lantibiotic Carboxyamide Derivatives With Enhanced Antibacterial Activity | SENTINELLA PHARMACEUTICALS, INC. (US) | 2012-03-01 | — | — | US | disclosed |
| US-20110081705-A1 | RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF | FRANANO F NICHOLAS | 2011-04-07 | — | — | US | disclosed |
| US-20110003855-A1 | ANTIVIRAL COMPOUNDS FOR THE TREATMENT OF HCV INFECTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-01-06 | — | — | US | disclosed |
| EP-0996455-B1 | ALPHA-O-LINKED GLYCOCONJUGATES WITH CLUSTERED (2,6)-ST EPITOPES, METHODS OF PREPARATION AND USES THEREOF | SLOAN KETTERING INST CANCER (US) | 2009-12-16 | — | — | EP | disclosed |
| US-20070224211-A1 | HIV-1 glycopeptides and derivatives; preparation and applications thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-09-27 | — | — | US | disclosed |
| EP-0914431-B1 | TRUNCATED SOLUBLE TUMOR NECROSIS FACTOR TYPE-I RECEPTORS | AMGEN INC (US) | 2007-06-13 | — | — | EP | disclosed |
| US-6359061-B1 | COMBINATORIAL LIBRARIES ARE USEFUL FOR SCREENING IN BIOLOGCAL ASSAYS IN ORDER TO IDENTIFY PHARMACEUTICALLY USEFUL COMPOUNDS | ISIS PHARMACEUTICALS, INC. | 2002-03-19 | — | — | US | disclosed |